It is likely that the risk of cardiovascular events from pharmaceuticals as COX-2 inhibitors can be reduced significantly by standard pharmaceutical and lifestyle preventative measures

✍ Scribed by H.R. Hellstrom

• Book ID: 117983366
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 90 KB
• Volume: 67
• Category: Article
• ISSN: 0306-9877
• DOI: 10.1016/j.mehy.2006.05.027